Changes in Patterns of Infection Associated with Pediatric Idiopathic Nephrotic Syndrome: A Single-Center Experience in Japan

Hiroyuki Takao(National Center For Child Health and Development), Koichi Kamei(National Center For Child Health and Development), Akira Ishiguro(National Center For Child Health and Development), Takanori Funaki(National Center For Child Health and Development), Shunsuke Yokota(National Center For Child Health and Development), Yuta Inoki(Kobe University), Taishi Nada(National Center For Child Health and Development), Kenji Ishikura(Kitasato University), Kei Osaka(National Center For Child Health and Development), Mai Sato(Kyoto University), Kentaro Nishi(National Center For Child Health and Development), Masao Ogura(Hokkaido University Hospital)
The Journal of Pediatrics
October 9, 2022
10.1016/j.jpeds.2022.10.005
Cited by 6

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135